OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product

OBiO Technology Corp., Ltd., a world leading contract development and manufacturing organization for cell and gene therapy, officially announced an agreement with Refreshgene Therapeutics.